Quantification of : Cross-Platform Comparison of One qPCR Assay with Leading Platforms and Six Master Mixes.

Diagnosis of pneumonia relies on nucleic acid quantification in respiratory samples. Lack of standardization among molecular assays results in significant differences among assays/centers. To further promote standardization, we compared four thermocyclers and six master mixes for the detection of . Whole nucleic acid (WNA) was extracted from broncho-alveolar lavages. Positive and negative sample extracts were pooled to get enough homogeneous materials. Three master mixes were tested to detect DNA by qPCR (D1, D2, and D3), and three to detect WNA by reverse transcriptase qPCR (W1, W2, and W3) manufactured by Roche, Eurogentec, Applied Biosystem, Invitrogen and Thermofischer Scientific. Experiments were performed on four thermocyclers (Roche LightCycler 480, Qiagen Rotor-Gene Q, Applied Biosystem ABI7500, and QuantStudio). Comparison of quantitative cycle () values between the methods targeting WNA versus DNA showed lower values for WNA, independently of thermocycler and master mix. For high and low fungal loads, ∆ values between DNA and WNA amplification were 6.97 (±2.95) and 5.81 (±3.30), respectively ( < 0.0001). Regarding DNA detection, lower s were obtained with D1 compared to D2 and D3, with median ∆ values of 2.6 ( = 0.015) and 2.9 ( = 0.039) respectively. Regarding WNA detection, no mix was superior to the others. PCR efficiency was not significantly different according to the qPCR platform ( = 0.14). This study confirmed the superiority of WNA over DNA detection. A calibration method (e.g., an international standard) for accurate comparative assessment of fungal load seems necessary.